Profound Medical Corp.
PRN.TO
TSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -46.35% | -101.05% | 43.04% | -35.34% | -5.07% |
| Total Depreciation and Amortization | -13.50% | -23.11% | -4.93% | -4.70% | -6.40% |
| Total Amortization of Deferred Charges | -- | -- | -402.22% | -- | -- |
| Total Other Non-Cash Items | 40.47% | 281.63% | -177.53% | -10.21% | -5.13% |
| Change in Net Operating Assets | -70.72% | 586.81% | -90.91% | 677.23% | -136.56% |
| Cash from Operations | -65.93% | -46.81% | 11.33% | -2.32% | -37.32% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | 44.55% | 21.35% | -10.10% | 3.05% |
| Issuance of Common Stock | -- | -- | -- | -100.00% | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 100.00% | -100.81% | 5,461.35% | -10.28% | -102.95% |
| Foreign Exchange rate Adjustments | 2,565.96% | 104.23% | -3,186.11% | 125.81% | 70.94% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -32.54% | -130.51% | 499.50% | 2.04% | -147.44% |